Researchers find new genetic links underlying progressively blinding eye disease

March 30, 2017

Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual corneal transplants.

Writing in the March 30 online issue of Nature Communications, researchers at University of California San Diego School of Medicine, with colleagues at Case Western University, Duke University, the National Institutes of Health and elsewhere, have identified three novel genomic loci -- distinct stretches of genetic material on chromosomes -- linked to FECD, which often clusters in families and is roughly 39 percent heritable.

"Previously, there was one known FECD locus. We've expanded that number to four," said the study's first author Natalie A. Afshari, MD, professor of ophthalmology, Stuart Brown MD Chair in Ophthalmology in Memory of Donald Shiley and chief of cornea and refractive surgery at Shiley Eye Institute at UC San Diego Health. "These findings provide a deeper understanding of the pathology of FECD, which in turn will help us develop better therapies for treating or preventing this disabling disease."

FECD affects the innermost layer of cells in the cornea (the transparent front cover of the eye), called the endothelium. The endothelium is responsible for maintaining the proper amount of fluid in the cornea, keeping it clear. FECD is a progressive disorder in which the endothelium slowly degrades, with lost clarity, pain and severely impaired vision. It affects 4 percent of the U.S. population above age 40 and worsens with age. Women are two to four times more affected than men. While there is symptomatic treatment in early stages, surgery -- often a corneal transplant -- is the only remedy after significant vision loss occurs.

The research team conducted a genome-wide association study, an analytical approach in which scientists look for genetic variants in individuals associated with a particular disease. This study involved 1,404 patients with FECD and 2,564 controls of European ancestry.

The results confirmed the known role of the TCF4 gene, but also revealed associations with three other loci: KANK4, LAMC1 and LINC009970/ATPB1. Researchers also found some genomic markers that were more associated by gender, with LAMC1 increasing FECD risk in women while TCF4 increased risk in men.

"While more work must be done to precisely elucidate what these proteins do," said Afshari, "the results suggest they have essential roles in sustaining and maintaining the health of the corneal endothelium. This knowledge improves our understanding of the genetic risk factors for FECD and gives us new therapeutic targets."
Co-authors include: senior author Sudha K. Iyengar, Robert P. Igo, Nathan J. Morris, V. Lakshmi Pulagam, Barbara J. Truitt and Jonathan H. Lass, Case Western Reserve University; Dwight Stambolian, University of Pennsylvania; Shiwani Sharma, Richard Mills Abraham Kuot, Sonja Klebe and Jamie E. Craig, Flinders University, Australia; Steven Dunn, Michigan Cornea Consultants; John F. Stamler and John H. Fingert, University of Iowa; Jacqueline Rimmler, Xuejin Qin, Mollie A. Minear, Elmer Balajonda, Simon G. Gregory, Gordon K. Klintworth and Yi-Ju Li, Duke University Medical Center; Christopher R. Croasdale, Davis Duer Dean Clinic, Madison, WI; Kathryn P. Burdon, Flinders University and University of Tasmania; S. Amer Riazuddin and John D. Gottsch, Johns Hopkins University School of Medicine; Jiagang Zhao, UC San Diego; George O. Rosenwasser, Central Pennsylvania Eye Institute; Keith H. Baratz and Sanjay V. Patel, Mayo Clinic; V. Vinod Mootha, University of Texas Southwestern Medical Center; Joan E. Bailey-Wilson, NIH; Marianne O. Price and Francis W. Price, Price Vision Group; and Anthony Aldave, UCLA.

University of California - San Diego

Related Ophthalmology Articles from Brightsurf:

Practice patterns, responsiveness to common ocular complaints among ophthalmology centers during COVID-19
Practice patterns for common ocular complaints during the initial stage of the COVID-19 pandemic are reported in this observational study among comprehensive U.S. ophthalmology practices.

Detection of COVID-19 viral material on environmental surfaces of an ophthalmology exam room
This study investigates the presence of SARS-CoV-2 on the environmental surfaces of an ophthalmology examination room after visits by patients who were asymptomatic and passed COVID-19 triage.

Ophthalmology after COVID-19
Changes in ophthalmology practices after the COVID-19 pandemic are discussed in this article.

Perspectives on COVID-19 control measures for ophthalmology clinics
This article describes treatment initiatives being undertaken for novel coronavirus 2019 at an ophthalmology center in Singapore.

Low risk of coronavirus spreading through tears
Study published today in the journal of the American Academy of Ophthalmology found no virus in tears of COVID-19 infected patients.

Low-cost, portable system takes OCT beyond ophthalmology
Researchers have developed a way to perform optical coherence tomography (OCT) in hard-to-reach areas of the body such as joints.

Relying on Dr. Google to diagnose eye problems may be dangerous to your health
A study examining the diagnoses generated by WebMD Symptom Checker showed the online tool was correct only 26 percent of the time.

American Academy of Ophthalmology reiterates long-standing guidance on LASIK education
The American Academy of Ophthalmology, the world's leading professional association of eye physicians and surgeons, today reiterated its long-standing guidance for patients considering LASIK vision correction surgery.

Burnout, depression can affect ophthalmology residents, study finds
A Brown University undergraduate led a JAMA Ophthalmology study showing that many ophthalmology residents face burnout and are often unable to participate in wellness initiatives, which has adverse consequences for both residents and patients.

Malcolm Gladwell published in the Journal of the American Academy of Ophthalmology
In his best sellers 'The Tipping Point,' 'Blink' and 'Outliers,' Malcolm Gladwell writes about the unexpected implications of scientific research, urging readers to think different.

Read More: Ophthalmology News and Ophthalmology Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to